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Background: Hydrogen sulfide (H2S) is an endogenously produced gaseous signaling molecule that induces cardioprotection via induction of 
antioxidant and anti-apoptotic defenses. We investigated H2S-mediated signaling in an in vivo murine model of heart failure (HF). 
Methods: HF was induced by subjecting mice (C57BL6/J) to 60 minutes of myocardial ischemia (MI) followed by reperfusion (R) for 4 weeks at 
which time 2-D echocardiography was performed to evaluate left ventricular (LV) dimensions and ejection fraction (EF). H2S (Na2S; 100 μg/kg), or 
saline was administered at the time of R (intracardiac) and then daily (i.v.) for the first 7 days following MI. In separate studies, mice were treated 
with H2S for 7 days and myocardial tissue was collected to evaluate potential cellular targets of H2S. 
Results: At 4 weeks of R, H2S therapy ameliorated LV dilatation and preserved ejection fraction compared to saline vehicle. Additional studies 
revealed that 7 days of H2S treatment increased the nuclear localization of both Nrf2 (p = 0.04 vs. vehicle) and nuclear respiratory factor 1 (NRF1; 
p=0.03), a transcription factor that is activated by Nrf2 and that regulates the mitochondrial genome. H2S also increased the phosphorylation of Akt 
(p = 0.04 vs. vehicle). 
Conclusions: Our results indicate that the transcription factors Nrf2 and NRF1 play a role in mediating the cardioprotective effects of H2S in the 
setting of HF.
